Contribute Try STAT+ Today

The Trump administration wants to increase how much Medicare pays for CAR-T cancer therapy and similar breakthrough devices and drugs that could substantially improve care for patients.

Seema Verma, administrator of the Centers for Medicare and Medicaid Services, said the agency will boost the size of extra payments it makes to help hospitals incorporate new technologies and treatments into their clinics. Medicare now pays 50 percent of the additional costs of these innovative treatments, but is proposing to increase that to 65 percent.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.